Steering Committee

Dean Kereiakes, MD
Medical Director, The Heart Center of Greater Cincinnati
and The Lindner Center at The Christ Hospital
Professor of Clinical Medicine,
Ohio State University

Dean J. Kereiakes, MD is Medical Director of The Christ Hospital Heart and Vascular Center; Medical Director of the Carl and Edyth Linder Center for Research Education; Chairman, Executive Committee of The Ohio Heart & Vascular Center; and Professor of Clinical Medicine at Ohio State University.

Dr. Kereiakes received his medical degree and was valedictorian of his graduating class at the University of Cincinnati in Ohio. His postgraduate training included internship and residency at the University of California, San Francisco, and a senior residency at Massachusetts General Hospital in Boston, and a chief residency at the University of California, San Francisco. He then completed fellowship in adult cardiology at the University of California, San Francisco and in coronary angioplasty at the San Francisco Heart Institute and the Sequoia Hospital. Dr. Kereiakes has been an investigator for most of the interventional technologies introduced in the last two decades and has performed more than 25,000 catheterization laboratory procedures.

In addition to lecturing nationally and internationally, Dr. Kereiakes is very active as a clinical and scientific investigator and has participated in over 800 clinical research protocols. He has published over 500 journal articles, abstracts, and book chapters. He serves on the editorial boards of Circulation, The Journal of American College of Cardiolog, The American Heart Journal, Journal of Invasive Cardiology, The American Journal of Cardiology and The Journal of Interventional Cardiology, as well as being a Section Editor for MedReviews (New Drugs Devices). He was previously a Section Editor for Circulation.

Dr. Kereiakes is a fellow of the American College of Cardiology. He was a member of the Joint American College of Cardiology/American Heart Association Task Force Committees to write guidelines for both coronary angioplasty and unstable angina. Dr. Kereiakes has been selected as Outstanding Alumnus University of Cincinnati School of Medicine, Who's Who in Medicine and Healthcare, Who's Who in Science and Engineering, Best Doctors in America and has received the Cincinnati Business Courier Health Care Hero - Innovator award and the Ohio Valley American Heart Association's Kaplan Visionary Award for cardiovascular research.

Paul A. Gurbel, MD
Director of Cardiovascular Research
Lifebridge Health
Associate Professor of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Paul A. Gurbel, MD is Director of Cardiovascular Research at Lifebridge Health and an Associate Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, MD. He also serves as the Associate Chief for Research of the Department of Medicine; Director of the Sinai Center for Thrombosis Research; and Director of Therapeutics, Research, and Technology Development for the Cardiac Catheterization Program, all at Sinai Hospital of Baltimore.

He earned his medical degree from the University of Maryland School of Medicine in Baltimore. He completed an internship and residency in the Department of Internal Medicine at Duke University Medical Center in Durham, NC and was also Chief Resident in Medicine at Duke. He completed a clinical fellowship in pulmonary and critical care at Johns Hopkins Hospital followed by fellowships in cardiology and interventional cardiology at Duke University Medical Center.

Dr. Gurbel is board certified in internal medicine with subspecialty certification in cardiovascular disease and interventional cardiology. He is a practicing interventional cardiologist in Baltimore, MD. He is a fellow of the American College of Cardiology, American College of Chest Physicians, and the Council on Clinical Cardiology of the American Heart Association. He is a member of the Duke University Clinical Cardiology Society and sits on the editorial board of Clinical Geriatrics. He is a manuscript reviewer of Arteriosclerosis, Thrombosis, and Vascular Biology; American Heart Journal; American Journal of Cardiology; Circulation; Journal of the American College of Cardiology; and Lancet.

Dr. Gurbel's research interests include thrombosis and vascular biology, innovations in catheter-based treatment of vascular disease, treatment of myocardial infarction, platelet activation in heart disease, antiplatelet therapy, and mechanisms and clinical effects of antiplatelet drug response variability. He is a member of the working group on aspirin resistance of the International Society of Thrombosis and Haemostasis. He has been the principal or coprincipal investigator of over 50 research trials and holds patents in the fields of interventional cardiology and platelet physiology. Dr. Gurbel has published 148 peer-reviewed articles in such journals as Atherosclerosis, Thrombosis and Vascular Biology, Circulation, Cardiology, American Journal of Cardiology, American Heart Journal, Journal of the American College of Cardiology, Journal of Thrombosis and Haemostasis, New England Journal of Medicine, Platelets, Thrombosis Research and Thrombosis, and Haemostasis.